Search Results

The country is also playing a key role in global clinical research, approving an average of 100 global clinical trials annually. (Representational image: Pixabay)
MedBound Blog

DCGI: India Now Supplies Drugs, Vaccines, and Medical Devices to Over 200 Nations

Vaishnavi Vilas Dalvi, B. Pharm
2 min read
DCGI Highlights India's Contributions to Global Healthcare; Pharmaceutical Industry's Future Directions
Medicine capsules global health with geometric pattern digital remix
Pharmacy

Glenmark Brings Advanced Blood Cancer Treatment to India with DCGI-Approved Brukinsa

M Subha Maheswari
2 min read
Glenmark Launches DCGI-Approved Brukinsa to Transform Blood Cancer Treatment in India
DCGI recalls 49 drugs from the market after quality lapses; spurious products traced to unauthorized sources. (Representational Image-Wikimedia Commons)
Medicine

DCGI Orders Recall of 49 drugs After Quality Issues, Action Against Spurious Drug Makers Initiated

Ankur Deka
2 min read
Batch-specific recall of painkillers, antifungals, and diabetes drugs; spurious products traced to unauthorized manufacturers
New code would help reduce increasing complexities in drug manufacturing, distribution etc. (PIXABAY)
Pharmacy

"DCGI" Issues Enhanced Code for Drug Inspectors : For Enhancing Transparency and Compliance in 2024

MBT Desk
3 min read
New code may have some implications for the pharmaceutical companies but would benefit consumers
The DCGI stated the anti-cancer drug that is mostly used to treat patients with gBRCA mutation, and those with advanced ovarian cancer & breast cancer is said to have adverse effects. (Representational image: Wikimedia Commons)
MedBound Blog

DCGI Orders Withdrawal of Anti-Cancer Drug Olaparib

MBT Desk
2 min read
The Drug Controller General of India has asked state and Union Territory regulators to withdraw AstraZeneca's cancer drug Olaparib
View of the Biocon Headquarters, Bengaluru, in the distance.
Pharmacy

Biocon Set to Launch Generic Wegovy in India and Canada by 2027

Dr. Pooja Bansal (PT)
3 min read
With global demand for obesity drugs rising, Biocon eyes post-2026 launch of generic Wegovy versions in India and Canada
Read More
logo
Medbound Times
www.medboundtimes.com